Correlation Between Bio Path and Soleno Therapeutics
Can any of the company-specific risk be diversified away by investing in both Bio Path and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Path and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Path Holdings and Soleno Therapeutics, you can compare the effects of market volatilities on Bio Path and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Path with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Path and Soleno Therapeutics.
Diversification Opportunities for Bio Path and Soleno Therapeutics
-0.08 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bio and Soleno is -0.08. Overlapping area represents the amount of risk that can be diversified away by holding Bio Path Holdings and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Bio Path is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Path Holdings are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Bio Path i.e., Bio Path and Soleno Therapeutics go up and down completely randomly.
Pair Corralation between Bio Path and Soleno Therapeutics
Given the investment horizon of 90 days Bio Path Holdings is expected to under-perform the Soleno Therapeutics. In addition to that, Bio Path is 1.95 times more volatile than Soleno Therapeutics. It trades about -0.24 of its total potential returns per unit of risk. Soleno Therapeutics is currently generating about 0.1 per unit of volatility. If you would invest 5,531 in Soleno Therapeutics on August 29, 2024 and sell it today you would earn a total of 303.00 from holding Soleno Therapeutics or generate 5.48% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bio Path Holdings vs. Soleno Therapeutics
Performance |
| Timeline |
| Bio Path Holdings |
| Soleno Therapeutics |
Bio Path and Soleno Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Path and Soleno Therapeutics
The main advantage of trading using opposite Bio Path and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Path position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.| Bio Path vs. Capricor Therapeutics | Bio Path vs. NextCure | Bio Path vs. Pulmatrix | Bio Path vs. Crinetics Pharmaceuticals |
| Soleno Therapeutics vs. Annexon | Soleno Therapeutics vs. Bolt Biotherapeutics | Soleno Therapeutics vs. Lyra Therapeutics | Soleno Therapeutics vs. Pulmatrix |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |